ArticleJournal of the American Society for Mass Spectrometry2025
Development and Characterization of a Fluorinated MS-Cleavable Cross-Linker for Structural Proteomics.
Article in Journal of the American Society for Mass Spectrometry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Intrinsic N-Terminal Reactivity and Improved Analysis of DSSO-Carbamate and Carbamate-Based Cross-Linkers.Analytical chemistry · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Cross-linking mass spectrometry (XL-MS) is an important method for studying three-dimensional protein structures and mapping protein-protein interactions. Some limitations of XL-MS still consist of its use for in-cell and in vivo applications. To date, cross-linking reagents are urgently needed that can efficiently penetrate the cell membrane to comprehensively map protein-protein interaction networks in intact cells. In this study, the fluorinated MS-cleavable cross-linker bis(pentafluorophenyl) ureido-4,4'-dibutyrate (DPFU) is described. DPFU is based on the MS-cleavable cross-linker disuccinimidyl dibutyric urea (DSBU) with the aim of balancing the hydrophobicity and solubility to improve membrane permeability. DPFU was evaluated for its solubility behavior in different detergent solutions to optimize conditions for its potential application in live cells. Using bovine serum albumin (BSA) as a model protein, XL-MS experiments were conducted across different temperatures and cross-linker concentrations. Solubility assays identified sodium dodecyl sulfate (SDS) as effective for enhancing DPFU solubility in an aqueous environment. DPFU yielded fewer cross-links for BSA than DSBU, highlighting limitations regarding its cross-linking efficiency under similar experimental conditions. This study provides the first insights into fluorinated cross-linkers, suggesting that further optimization is needed for a broader application of DPFU for future in-cell XL-MS studies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.